The Deciparticle ™ platform is a proprietary nanotechnology engineered to encapsulate hydrophobic molecules as uniform, sub-20 nm nanoparticles for intravenous administration. The platform improves ...

Millions of people take some kind of dietary supplement along with prescription medications. Here are the supplements and ...

Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano, a clinical-stage nanomedicine company, today announced new data ...

Millions of Brits are told to avoid one specific fruit for important health reasons. Recent figures from the NHS Business Services Authority (NHSBSA) reveal that 8.7 million people across the UK are ...

Kura Oncology will host a conference call on November 13, 2025, at 12:30 pm ET / 9:30 am PT – SAN DIEGO and TOYKO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA) and Kyowa Kirin ...

Lundbeck A/S (Lundbeck) today announced that new pipeline data regarding bexicaserin (LP352), a novel investigational drug for the treatment of seizures associated with Developmental and Epileptic ...

AI WAS a highlight of the 2025 European Society for Medical Oncology (ESMO) Congress, held in Berlin, Germany, with sessions ...

Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received ...

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated that ivermectin "preferentially targets renal cancer through inducing ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call ...

Praxis Precision Medicines, Inc. is upgraded to Strong Buy, driven by pipeline progress and positive Phase 3 data for ...

Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease December 1, 2025 8:00 ...